Home › Products › Endocrinology › Novomix 30 Flexpen 100IU
Novomix 30 Flexpen 100IU
Salt Composition: INSULIN ASPART,INSULIN ASPART PROTAMINE
- Manufacturer: NOVO NORDISK INDIA PVT LTD
- Pack Size: 1 PEN DEVICE(s)
- Dosage Form: PEN
- Strength: 100IU
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store Novomix 30 Flexpen 100IU at 2-8°C. Discard the unused solution after 28 days.
₹1042.00₹1157.97
Inclusive of all taxes
Product Introduction
Novomix 30 Flexpen 100IU contains insulin aspart and insulin aspart protamine. It is a combination of two insulin types: insulin aspart (rapid-acting insulin) and insulin aspart protamine (intermediate-acting insulin). It is used to treat diabetes mellitus, a chronic condition characterised by elevated blood glucose levels. In diabetes, your body does not produce sufficient insulin to control blood glucose levels. Blood sugar monitoring with a home blood sugar meter (glucometer) is necessary.
When blood sugar remains elevated for prolonged periods, patients with diabetes may experience increased urination, thirst, nausea or vomiting, drowsiness or fatigue, abdominal pain, facial flushing, and fruity (acetone) breath odour. These may indicate diabetic ketoacidosis, a serious condition involving acid build-up in the blood due to the body breaking down fat instead of glucose. Seek immediate medical attention if you experience these symptoms.
This injection may cause injection site reactions such as pain, redness, itching, or swelling. These reactions are typically mild and resolve without intervention, but contact your doctor immediately if they persist or become severe.
This medicine is not recommended for use in children under 2 years of age. Intravenous administration is not intended, as intravenous insulin use can lead to hypoglycaemia, hypokalaemia, or other serious adverse effects.
Novomix 30 Flexpen 100IU should be used with caution in patients with severe hepatic (liver) or renal (kidney) impairment, as insulin requirements may be reduced. Certain medications such as corticosteroids may affect blood sugar control and require insulin dose adjustment.
If you are pregnant or planning pregnancy, consult your doctor before using this penfill. During pregnancy, insulin requirements may change, and close blood sugar monitoring is important to ensure optimal glucose control for both mother and developing fetus. If you are already using this injection and become pregnant, do not discontinue insulin without first consulting your doctor. Maintaining good glucose control during pregnancy is important to minimise the risk of complications for both you and your baby.
Uses
Novomix 30 Flexpen 100 IU uses are: Diabetes Mellitus
How it works
Novomix 30 Flexpen 100IU works by binding to the insulin receptors on the fat and muscle cells and inhibiting glucose release from the liver. It enables the absorption of glucose by the cells and regulates glucose metabolism thereby helping to prevent blood sugar levels from rising too high.
How to Use
It should only be administered by a trained doctor or nurse. It will be given shortly before a meal. Novomix 30 Flexpen 100IU will be given as a subcutaneous injection, which means that the insulin is injected into the fatty tissue just beneath the skin, using a needle and syringe or a prefilled insulin pen device. Your doctor will decide the Novomix 30 Flexpen 100 IU dosage and duration of the treatment based on your disease severity and other factors. Do not self-administer the medication.
Side Effects
Novomix 30 Flexpen 100 IU side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Allergies Low blood sugar levels Breathing trouble Dizziness Confusion Common Itching Rash Reactions at injection site Weight gain Low potassium levels in the blood
References
- Package leaflet: Information for the User Novomix- medicines. Available at: https://www.medicines.org.uk/emc/files/pil.7920.pdf (Accessed: April 24, 2023).
- Ema (2021) Novomix, European Medicines Agency. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/novomix (Accessed: April 24, 2023).
- Product monograph including Patient Medication Information - Novo Nordisk. Available at: https://www.novonordisk.ca/content/dam/Canada/AFFILIATE/www-novonordisk-ca/OurProducts/PDF/novomix30-product-monograph.pdf (Accessed: April 24, 2023).
- Insulin aspart protamine and insulin Aspart Mix 70/30 PI. Available at: https://www.novo-pi.com/insulinaspartmix.pdf (Accessed: April 24, 2023).
- E.R. Pearson, R.J. McCrimmon, Diabetes mellitus, Davidson's Principles & Practice of Medicine, 22nd Edition, 2014, 797-836.
Safety Advice
Pregnancy: Consult your doctor If you are pregnant, think you may be pregnant or are planning to have a baby, consult with your doctor for advice before taking this Novomix 30 Flexpen 100IU.
Lungs: Consult your doctor It is unknown whether Novomix 30 Flexpen 100IU can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: Consult your doctor There is limited data available on the safety of using Novomix 30 Flexpen 100IU during breastfeeding. Please consult your doctor before taking this medicine.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.